HSIC vs. PDCO, ROIV, VKTX, RGEN, CHE, EHC, QGEN, ASND, TFX, and LEGN
Should you be buying Henry Schein stock or one of its competitors? The main competitors of Henry Schein include Patterson Companies (PDCO), Roivant Sciences (ROIV), Viking Therapeutics (VKTX), Repligen (RGEN), Chemed (CHE), Encompass Health (EHC), Qiagen (QGEN), Ascendis Pharma A/S (ASND), Teleflex (TFX), and Legend Biotech (LEGN). These companies are all part of the "medical" sector.
Henry Schein (NASDAQ:HSIC) and Patterson Companies (NASDAQ:PDCO) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, community ranking, profitability, media sentiment, earnings, risk and valuation.
Henry Schein received 7 more outperform votes than Patterson Companies when rated by MarketBeat users. However, 52.41% of users gave Patterson Companies an outperform vote while only 51.55% of users gave Henry Schein an outperform vote.
Henry Schein presently has a consensus price target of $81.09, suggesting a potential upside of 17.90%. Patterson Companies has a consensus price target of $32.56, suggesting a potential upside of 27.92%. Given Patterson Companies' higher probable upside, analysts plainly believe Patterson Companies is more favorable than Henry Schein.
96.6% of Henry Schein shares are held by institutional investors. Comparatively, 85.4% of Patterson Companies shares are held by institutional investors. 1.1% of Henry Schein shares are held by company insiders. Comparatively, 1.5% of Patterson Companies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Henry Schein has higher revenue and earnings than Patterson Companies. Patterson Companies is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.
Henry Schein has a net margin of 3.37% compared to Patterson Companies' net margin of 2.95%. Patterson Companies' return on equity of 20.98% beat Henry Schein's return on equity.
In the previous week, Patterson Companies had 9 more articles in the media than Henry Schein. MarketBeat recorded 13 mentions for Patterson Companies and 4 mentions for Henry Schein. Henry Schein's average media sentiment score of 0.78 beat Patterson Companies' score of 0.15 indicating that Henry Schein is being referred to more favorably in the media.
Henry Schein has a beta of 0.87, indicating that its share price is 13% less volatile than the S&P 500. Comparatively, Patterson Companies has a beta of 1.06, indicating that its share price is 6% more volatile than the S&P 500.
Summary
Henry Schein beats Patterson Companies on 11 of the 18 factors compared between the two stocks.
Get Henry Schein News Delivered to You Automatically
Sign up to receive the latest news and ratings for HSIC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HSIC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Henry Schein Competitors List
Related Companies and Tools
